The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, T. Rowe Price Group Inc. (NASDAQ: TROW) closed at $108.72 down -2.40% from its previous closing price of $111.39. In other words, the price has decreased by -$2.40 from its previous closing price. On the day, 2.48 million shares were traded. TROW stock price reached its highest trading level at $111.75 during the session, while it also had its lowest trading level at $108.27.
Ratios:
For a deeper understanding of T. Rowe Price Group Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.63. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Keefe Bruyette on April 11, 2024, Upgraded its rating to Mkt Perform and sets its target price to $120 from $106 previously.
On April 08, 2024, TD Cowen Upgraded its rating to Hold which previously was Sell and also upped its target price recommendation from $92 to $114.
Wells Fargo Downgraded its Equal Weight to Underweight on January 08, 2024, whereas the target price for the stock was revised from $95 to $105.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 08 ’24 when HRABOWSKI FREEMAN A III sold 8,740 shares for $118.32 per share. The transaction valued at 1,034,147 led to the insider holds 21,073 shares of the business.
Hiebler Jessica M sold 1,138 shares of TROW for $121,913 on Feb 09 ’24. The Principal Accounting Officer now owns 14,113 shares after completing the transaction at $107.13 per share. On Dec 18 ’23, another insider, Thomson Andrew Justin Mackenzi, who serves as the Vice President of the company, sold 11,969 shares for $105.91 each. As a result, the insider received 1,267,618 and left with 123,624 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TROW now has a Market Capitalization of 24314576896 and an Enterprise Value of 23433345024. As of this moment, T.’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.01, and their Forward P/E ratio for the next fiscal year is 12.60. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 20.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.76 while its Price-to-Book (P/B) ratio in mrq is 2.56. Its current Enterprise Value per Revenue stands at 3.627 whereas that against EBITDA is 9.3.
Stock Price History:
Over the past 52 weeks, TROW has reached a high of $132.76, while it has fallen to a 52-week low of $87.43. The 50-Day Moving Average of the stock is -4.99%, while the 200-Day Moving Average is calculated to be 0.21%.
Shares Statistics:
For the past three months, TROW has traded an average of 1.34M shares per day and 1501730 over the past ten days. A total of 223.94M shares are outstanding, with a floating share count of 218.63M. Insiders hold about 2.24% of the company’s shares, while institutions hold 75.77% stake in the company. Shares short for TROW as of 1711584000 were 11356130 with a Short Ratio of 8.49, compared to 1709164800 on 12147109. Therefore, it implies a Short% of Shares Outstanding of 11356130 and a Short% of Float of 5.88.
Dividends & Splits
According to the company, the forward annual dividend rate for TROW is 4.90, from 4.88 in the trailing year. The stock’s 5-year Average Dividend Yield is 3.17.
Earnings Estimates
The market rating of T. Rowe Price Group Inc. (TROW) is currently shaped by the ongoing analysis conducted by T. Rowe Price Group, Inc. analysts closely monitoring its performance.The consensus estimate for the next quarter is $10.85, with high estimates of $21.90 and low estimates of $15.95.
Analysts are recommending an EPS of between $Financial Services and $Basic Materials for the fiscal current year, implying an average EPS of $Healthcare.
